Delayed Infusion Reactions to Enzyme Replacement Therapies-Reference-Cited by-同舟云学术

Delayed Infusion Reactions to Enzyme Replacement Therapies

Published:2016 Issue: Volume: Page:63-70
ISSN:2192-8304
Container-title:JIMD Reports
language:
Short-container-title:

Author:

Karimian Zahra,Whitley Chester B.,Rudser Kyle D.,Utz Jeanine R. Jarnes

Publisher

Springer Berlin Heidelberg

Link

http://link.springer.com/content/pdf/10.1007/8904_2016_8

Reference19 articles.

1. Aldurazyme® [package insert] (2002) BioMarin, San Rafael, CA. Downloadable full U.S. prescribing information is available at: https://www.genzyme.com/Products/Product-Information.aspx (Retrieved from 4-21-2016). Accessed 14 Sept 2015

2. Cerezyme® [package insert] (2014) Genzyme, Cambridge, MA. Downloadable full U.S. prescribing information is available at: https://www.genzyme.com/Products/Product-Information.aspx (Retrieved from 4-21-2016). Accessed 14 Sept 2015

3. Elaprase® [package insert] (2014) BioMarin, San Rafael, CA. Downloadable full U.S. prescribing information is available at: http://elaprase.com/ (Retrieved from 4-21-2016). Accessed 14 Sept 2015

4. Elelyso® [package insert] (2012) Pfizer, New York, NY. Downloadable full U.S. prescribing information is available at: http://www.elelyso.com/ (Retrieved from 4-21-2016). Accessed 14 Sept 2015

5. Fabrazyme® [package insert] (2003) Genzyme, Cambridge, MA. Downloadable full U.S. prescribing information is available at: https://www.genzyme.com/Products/Product-Information.aspx (Retrieved from 4-21-2016). Accessed 14 Sept 2015

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Allergic reactions to enzyme replacement therapy in children with lysosomal storage diseases and their management;Journal of Pediatric Endocrinology and Metabolism;2024-09-04

2. Home-Based Infusion of Alglucosidase Alfa Can Safely be Implemented in Adults with Late-Onset Pompe Disease: Lessons Learned from 18,380 Infusions;BioDrugs;2023-06-16

3. Novel approach to idursulfase and laronidase desensitization in type 2 and type 1 S mucopolysaccharidosis (MPS);Orphanet Journal of Rare Diseases;2022-11-03

4. Physiologically‐Based Pharmacokinetic Model Development, Validation, and Application for Prediction of Eliglustat Drug–Drug Interactions;Clinical Pharmacology & Therapeutics;2022-09-30

5. Reacciones de hipersensibilidad a alglucosidasa alfa en enfermedad de Pompe: dos casos de desensibilización exitosa;Medicina y Laboratorio;2022-07-01